title: Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001).
authors.affiliation: Institut Bergonié, Bordeaux, France.
authors.forename: L
authors.initials: L
authors.lastname: Mauriac
authors.forename: E
authors.initials: E
authors.lastname: Luporsi
authors.forename: B
authors.initials: B
authors.lastname: Cutuli
authors.forename: A
authors.initials: A
authors.lastname: Fourquet
authors.forename: J R
authors.initials: JR
authors.lastname: Garbay
authors.forename: S
authors.initials: S
authors.lastname: Giard
authors.forename: F
authors.initials: F
authors.lastname: Spyratos
authors.forename: B
authors.initials: B
authors.lastname: Sigal-Zafrani
authors.forename: J M
authors.initials: JM
authors.lastname: Dilhuydy
authors.forename: V
authors.initials: V
authors.lastname: Acharian
authors.forename: C
authors.initials: C
authors.lastname: Balu-Maestro
authors.forename: M P
authors.initials: MP
authors.lastname: Blanc-Vincent
authors.forename: C
authors.initials: C
authors.lastname: Cohen-Solal
authors.forename: B
authors.initials: B
authors.lastname: De Lafontan
authors.forename: M H
authors.initials: MH
authors.lastname: Dilhuydy
authors.forename: B
authors.initials: B
authors.lastname: Duquesne
authors.forename: R
authors.initials: R
authors.lastname: Gilles
authors.forename: A
authors.initials: A
authors.lastname: Lesur
authors.forename: N
authors.initials: N
authors.lastname: Shen
authors.forename: L
authors.initials: L
authors.lastname: Cany
authors.forename: I
authors.initials: I
authors.lastname: Dagousset
authors.forename: M H
authors.initials: MH
authors.lastname: Gaspard
authors.forename: H
authors.initials: H
authors.lastname: Hoarau
authors.forename: A
authors.initials: A
authors.lastname: Hubert
authors.forename: M H
authors.initials: MH
authors.lastname: Monira
authors.forename: N
authors.initials: N
authors.lastname: Perrié
authors.forename: G
authors.initials: G
authors.lastname: Romieu
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003663:Decision Trees; D005260:Female; D005602:France; D006287:Health Planning Guidelines; D006801:Humans; D008408:Mastectomy; D015201:Meta-Analysis as Topic; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D012015:Reference Standards; D012106:Research
chemical_list: D000970:Antineoplastic Agents